Northern Trust Company of Connecticut’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
$27.9M Sell
146,191
-334
-0.2% -$62.2K 0.17% 134
2013
Q3
$24.8M Buy
146,525
+931
+0.6% +$145K 0.16% 156
2013
Q2
$22.1M Buy
+145,594
New +$20.6M 0.15% 174

Other funds holding CLB

Northern Trust Company of Connecticut's CLB Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Core Laboratories (CLB) stake by 0.23% in Q4 2013, selling an estimated $62.2K and leaving 146,191 shares worth $27.9M. The position accounts for 0.17% of the portfolio, ranked #134.

Northern Trust Company of Connecticut first reported a position in CLB in Q2 2013 and has held it in 3 quarters since. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2013.

  • Northern Trust Company of Connecticut held 146,191 shares of Core Laboratories worth $27.9M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 334 Core Laboratories shares in Q4 2013, an estimated $62.2K.
  • Core Laboratories made up 0.17% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #134 holding.
  • Northern Trust Company of Connecticut first reported a position in Core Laboratories in Q2 2013 and has held it in 3 quarters since.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.